Skip to content

Clinical trials

Lung Neoplasms trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Peru Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20091
20141
20152
20181
20202
20212
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
AstraZeneca3
Alliance for Clinical Trials in Oncology1
Amgen1
Bristol-Myers Squibb1
Checkpoint Therapeutics, Inc.1
Eastern Cooperative Oncology Group1
Fundación GECP1
International Atomic Energy Agency1
NCIC Clinical Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms17
Carcinoma, Non-Small-Cell Lung13
Adenocarcinoma of Lung2
Adenocarcinoma, Bronchiolo-Alveolar2
Carcinoma1
Neoplasm Metastasis1
Neoplasms1
Sexual Dysfunction, Physiological1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.